PAODPeripheral Arterial Occlusive Disease
PAODPeripheral Arterial Obliterative Disease (biomedicine)
PAODPost Academisch Onderwijs Diergeneeskunde (Dutch: Postgraduate Education Veterinary Medicine; Merelbeke, Belgium)
References in periodicals archive ?
In present study we found more number of the cases of PAOD positive for stenosis with CDUS than CTA, in comparison to the study conducted by Kayhan A et al.
Those risks were most prominent in elderly patients and in people with kidney and other health problems, which are common in PAOD.
Buflomedil is a vasoactive agent used to treat the PAOD symptoms such as pain and weakness in the legs, which occur due to obstruction in the large arteries.
Risk factors for PAOD in the general population include advancing age, hypertension, smoking, diabetes, and coronary artery disease (O'Hare & Johansen, 2001).
Categories of risk included demo graphic variables such as age and gender, clinical comorbidities, anatomical deformities, laboratory values, smoking history, sensation (detected by the application of 6 gm monofilaments to ten sites on each foot and by a four-item history of symptoms), presence of pedal pulses by palpation and by doppler, physical findings of PAOD, SCBs, and capacity for self-care of feet.
Several well-designed cross-sectional and case-control studies have clearly shown evidence that tHcy is a major independent risk factor for PAOD, cardiovascular morbidity, and death (10-12).
Aims and objectives of this prospective comparative study was to compare the findings of Color Doppler with digital subtraction arteriography as the gold standard, in PAOD of infragenicular arteries of the lower extremities.
Koelemay et al in their review article concluded that CD is an excellent tool in the noninvasive work up of patients with PAOD, in aortoiliac and femoropopliteal segment.
11,12) Koelemay et al, (17) in their review article, concluded that CFD is an excellent tool in the noninvasive work up of patients with PAOD, in aortoiliac and femoropopliteal segment.
The recurring theme in these failed trials has been that no existing treatment can increase walking distance in patients with PAD or PAOD.
In mild to moderate PAOD, the increased resistance to blood flow will lead to decreased flow capacity during limb exercise which can lead to limb ischemia.
SonoLysis represents a potentially important advance in treating vascular diseases such as PAOD as it may increase safety and reduce treatment times by limiting the use of a lytic drug.